Correction of increased sympathoadrenal activity in Bartter's syndrome by inhibition of prostaglandin synthesis.
D000293:Adolescent; D000311:Adrenal Glands / Q000503:physiopathology*; D000328:Adult; D001477:Bartter Syndrome / Q000503:physiopathology*; D004837:Epinephrine / Q000097:blood / Q000652:urine; D005260:Female; D006801:Humans; D006929:Hyperaldosteronism / Q000503:physiopathology*; D007213:Indomethacin; D008676:Metanephrine / Q000652:urine; D008875:Middle Aged; D009638:Norepinephrine / Q000652:urine; D011188:Potassium / Q000097:blood; D011453:Prostaglandins / Q000096:biosynthesis*; D014642:Vanilmandelic Acid / Q000652:urine
D011453:Prostaglandins; D008676:Metanephrine; D014642:Vanilmandelic Acid; D011188:Potassium; D009638:Norepinephrine; D007213:Indomethacin; D004837:Epinephrine